28.02.2014 • NewsDede WillamsEastmanmarkets and companies

Eastman Board Approves $1 Billion Share Buyback

The board of U.S. chemical producer Eastman has approved the repurchase of up to $1 billion of the company's common stock. Chief financial officer Curt Espeland said the buyback and the quarterly cash dividend of $0.35 per share reflects the company's solid financial position, including its strong cash flow.

Eastman said the share repurchases will be made from time to time in either the open market or private transactions. The timing, volume and nature of the repurchases will be at the discretion of management, subject to market conditions and may be suspended or discontinued at any time.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.